VIVUS Announces Date of Fourth Quarter 2015 Update and Financial Results Teleconference
Date: March 9, 2016
Time: 4:30 PM EST
Listen via Internet: http://ir.vivus.com/
Webcast Link: http://edge.media-server.com/m/p/3aysciy5
Dial in: 1 224 357-2386
Dial in (Toll-Free): 1 877-359-2916
Audience Passcode: 5812 2612
A webcast replay will be available on the VIVUS website for 30 days.
VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.
Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and as amended by the Form 10-K/A filed on April 30, 2015, and periodic reports filed with the Securities and Exchange Commission.
CONTACT:
Chief Financial Officer
650-934-5268
oki@vivus.com
(Managing Director)
646-378-2923
bkorb@troutgroup.com
Source:
News Provided by Acquire Media